Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1984
11/13/1984US4482544 Compounds for treating hypertension
11/13/1984US4482543 Biologically active substance, process for preparing the substance and immunoactive composition
11/13/1984US4482488 Antibiotic A53868 and process for production thereof
11/13/1984US4482487 A-21978C cyclic peptides
11/13/1984US4482486 Analogs of vasopressin
11/13/1984US4482485 Method of preparation of human urine origin colony-stimulating factor and kallikrein
11/13/1984US4482483 Albumin, sodium choride, carbohydrate
11/13/1984CA1177825A1 Polypeptide analgesics
11/08/1984WO1984004306A1 Fused 7-membered ring compounds and process for their preparation
11/08/1984WO1984004301A1 New oligopeptide aldehydes useful as specific inhibitors of enterokinase
11/08/1984WO1984004249A2 Composition having an improved pharmaceutical activity and utilisation thereof in veterinary medecine
11/08/1984WO1984004248A1 Modified crosslinked stroma-free tetrameric hemoglobin
11/07/1984EP0124506A2 Method of inactivating pathogens
11/07/1984EP0124420A2 Gastric secretion inhibiting peptide derivatives, process for their preparation and medicines containing them
11/07/1984EP0124363A2 Photochemical decontamination treatment of whole blood or blood components
11/07/1984EP0124343A1 Actaplanin antibiotics
11/07/1984EP0124317A2 Proline derivatives
11/07/1984EP0124243A1 Compounds medicaments and apparatus for controlling blood pressure
11/07/1984EP0124044A2 Process for pasteurizing fibronectin
11/07/1984EP0124018A1 Pharmaceutical preparation containing purified fibronectin
11/07/1984EP0123951A2 Intermediates for thymosin alpha 1
11/07/1984EP0123950A2 Intermediates for thymosin alpha 1 and desacetylthymosin alpha 1
11/07/1984EP0123948A1 External pharmaceutical composition
11/07/1984EP0123945A1 New factor VIII coagulant polypeptides
11/07/1984EP0123877A2 Methods for preparing Protein compositions substantially free from infections agents
11/07/1984EP0032927B1 System for the controlled release of biologically active substances to a body fluid
11/06/1984US4481194 Diuretics
11/06/1984US4481193 Diuretics
11/06/1984US4481192 Acid-protease inhibiting peptide derivatives
11/06/1984US4481191 Method for controlling blood pressure
11/06/1984US4481190 Luteinizing hormone releasing hormone
11/06/1984US4481189 Inactivation of hepatitis b virus
11/06/1984US4481139 Peptide antagonists of substance P
11/06/1984US4481138 Analgesic
11/06/1984US4481137 Antitumor agents from cell cultures
11/06/1984CA1177401A1 Method of using motility increasing peptides
10/1984
10/31/1984EP0123543A1 Leukotriene antagonists, their production and use and compositions containing them
10/31/1984EP0123304A2 A method for stabilizing tissue plasminogen activator and a stable aqueous solution or powder containing the same
10/31/1984EP0123291A2 Method for stabilizing interferon
10/31/1984EP0123170A2 Antibiotic LL-D05139beta
10/31/1984EP0123029A1 Process for the production of a solution of IgG-immunoglobulin free of secondary effect for intravenous application
10/31/1984EP0122926A1 Immune stimulator
10/30/1984US4480032 Natural mixture of Type I and Type II interferons
10/30/1984US4479940 Transferring drugs to central nervous system
10/30/1984US4479938 Therapeutic composition containing factor VIIa
10/30/1984US4479937 Process of treating inflammation with human urinary thiol protease inhibitor
10/30/1984US4479934 Fc-reagent
10/30/1984US4479932 Brain-specific drug delivery
10/30/1984US4479898 Oligopeptide prodrugs
10/30/1984US4479897 Actaplanin antibiotics
10/30/1984US4479861 Method and apparatus for preparative gel electrophoresis
10/30/1984CA1177069A1 Phenyl ketones
10/24/1984EP0122909A1 Fraction containing immunoglobulin-G
10/24/1984EP0122818A1 Liquid-phase synthesis of hpGRF (Somatocrinin) and intermediate peptides
10/24/1984EP0122814A2 A method of cotransformation, cotransformed mouse cells producing at their surface human class II antigens and the use of those cells to generate mouse hybridomas that produce monoclonal antibodies to those antigens
10/24/1984EP0122798A2 rCRF and analogs
10/24/1984EP0122712A2 GnRH antagonists
10/24/1984EP0122558A2 Improved composition of intravenous immune globulin
10/23/1984US4478830 Hypoglycemic agents
10/23/1984US4478829 Buffer, sodium chloride, carbohydrate, surfactant
10/23/1984US4478828 Nonapeptide having immunostimulative activity, process for the preparation thereof, and its use
10/23/1984US4478827 Renin inhibitors
10/23/1984US4478826 Treatment of hypertension and hyperaldosteronism
10/23/1984US4478825 Warm ethanol method for preparation of low fibrinogen antihemophilic factor
10/23/1984US4478746 Glycosylated insulin derivatives
10/23/1984US4478745 Anticoagulants
10/23/1984CA1176565A1 Microencapsulation of water soluble polypeptides
10/23/1984CA1176563A1 Therapeutic compositions and methods for manufacture and use
10/23/1984CA1176560A1 Process for determining inhibitor-enzyme complexes and composition for use therein
10/18/1984EP0097648A4 Synthetic whole blood and a method of making the same.
10/17/1984EP0122036A1 Powdery pharmaceutical composition for nasal administration
10/17/1984EP0121995A2 Peptides
10/17/1984EP0121976A2 Partially purified osteogenic factor and process for preparing same from demineralized bone or an osteosarcoma
10/17/1984EP0121912A1 Radio immunoassay for the determination of thymosin-beta-4
10/17/1984EP0121830A2 Substituted dipeptides as antihypertensives
10/17/1984EP0121788A2 Process for the preparation of the alpha-amylase inactivator tendamistat in a crystalline form
10/17/1984EP0121764A2 Polypeptides
10/16/1984US4477434 Medicinal compositions, foods and beverages having therapeutic effects on diseases of circulatory system and digestive system
10/16/1984EP0092583A4 Telecommunications cable and method of making same.
10/16/1984CA1176193A1 Peptide, process for their preparation and pharmaceutical composition containing them
10/16/1984CA1176163A1 Stabilization of factor viii activity in whole blood or plasma
10/16/1984CA1176162A1 N-terminal fragment of human pro-opiomelanocortin and process therefor
10/16/1984CA1176161A1 Pharmaceutical formulations comprising human insulin and human proinsulin
10/16/1984CA1176160A1 Human proinsulin pharmaceutical formulations
10/16/1984CA1176159A1 Pharmaceutical formulations comprising human insulin, human c-peptide, and human proinsulin
10/16/1984CA1176158A1 Pharmaceutical formulations comprising human insulin and human c-peptide
10/11/1984WO1984003946A1 Cell matrix receptor system and use in cancer diagnosis and management
10/10/1984EP0121468A2 Process for the fractionation of blood plasma
10/10/1984EP0121338A1 Biosynthetically produced human nerve growth factor, process for producing it, compositions containing it, DNA sequence encoding it, vectors containing the sequence and host cells transformed thereby
10/10/1984EP0121157A1 Novel human interferon-gamma polypeptide
10/10/1984EP0121036A1 Product for controlled triglyceride nutrition of hypercatabolic mammals
10/09/1984US4476299 Extraction of rubia
10/09/1984US4476118 Stabilized insulin preparations
10/09/1984US4476117 Antigonists narcotics
10/09/1984US4476116 Hormones; proteins; enzymers
10/09/1984US4476050 Peptide, process for preparation thereof and use thereof
10/09/1984US4476049 With protease inhibitor
10/09/1984CA1175810A1 Synthetic peptides having pituitary growth hormone releasing activity
10/09/1984CA1175742A1 Process for the manufacture of globin or blood cell protein and heme from hemoglobin
10/09/1984CA1175741A1 Composition and method for the treatment of cancer
1 ... 3118 3119 3120 3121 3122 3123 3124 3125 3126 3127 3128 3129 3130 3131 3132 3133 3134 3135 3136 3137 3138 ... 3163